FERNANDO
ALFONSO MANTEROLA
Investigador en el periodo 2008-2013
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (16)
2024
-
A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study
JACC: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 756-767
2022
-
Balloon-assisted tracking deployment of a coronary sinus reducer through a Vieussens valve
Cardiology journal, Vol. 29, Núm. 2, pp. 360-361
-
Vascular healing responses to paclitaxel coated balloons or everolimus eluting stents for the treatment of in-stent restenosis. Insights from optical coherence tomography
Coronary Artery Disease, Vol. 33, Núm. 8, pp. 609-617
2021
-
Age and Gender influence on time of arrival for STEMI patients during Covid-19 pandemic
American Journal of Emergency Medicine
-
Influence of neoatherosclerosis on prognosis and treatment response in patients with in-stent restenosis
Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 427-435
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
2016
-
Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry)
American Journal of Cardiology, Vol. 118, Núm. 4, pp. 578-584
2015
-
A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial
Journal of the American College of Cardiology, Vol. 66, Núm. 1, pp. 23-33
2014
-
A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)
Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386
2013
-
Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry)
American Journal of Cardiology, Vol. 111, Núm. 5, pp. 676-683
2012
-
Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis: Results from a prospective multicenter study (RIBS III [restenosis intra-stent: Balloon angioplasty versus drug-eluting stent])
JACC: Cardiovascular Interventions, Vol. 5, Núm. 7, pp. 728-737
-
¿Qué aportan las guías europeas de revascularización?
Revista Espanola de Cardiologia Suplementos, Vol. 12, Núm. SUPPL. 1, pp. 14-20
2011
-
Primary percutaneous coronary intervention for ST-segment elevation acute myocardial infarction in nonagenarian patients: Results from a Spanish multicentre registry
EuroIntervention, Vol. 6, Núm. 9, pp. 1080-1084
2010
-
Thrombosis of second-generation drug-eluting stents in real practice: Results from the multicenter Spanish registry ESTROFA-2 (estudio espaol sobre trombosis de stents farmacoactivos de segunda generacion-2)
JACC: Cardiovascular Interventions, Vol. 3, Núm. 9, pp. 911-919
2007
-
Clinical impact of in-stent late loss after drug-eluting coronary stent implantation
European Heart Journal, Vol. 28, Núm. 13, pp. 1583-1591
-
Meta-Analysis Comparing the Effect of Drug-Eluting Versus Bare Metal Stents on Risk of Acute Myocardial Infarction During Follow-Up
American Journal of Cardiology, Vol. 99, Núm. 5, pp. 621-625